Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 June 2004, Vol. 103, No. 11, pp. 4119-4125.
Prepublished online as a Blood First Edition Paper on February 12, 2004; DOI 10.1182/blood-2003-10-3518.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-10-3518v1
103/11/4119    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellanne-Chantelot, C.
Right arrow Articles by Donadieu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellanne-Chantelot, C.
Right arrow Articles by Donadieu, J.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted October 15, 2003
Accepted February 4, 2004

Mutations in the ELA2 gene correlate with more severe expression of neutropenia: A study of 81 patients from the French Neutropenia Register

Christine Bellanne-Chantelot*, Severine Clauin, Thierry Leblanc, Bruno Cassinat, Fernando Rodrigues-Lima, Sandrine Beaufils, Christelle Vaury, Mohamed Barkaoui, Odile Fenneteau, Micheline Maier-Redelsperger, Christine Chomienne, and Jean Donadieu

Laboratoire Embryologie Pathologique et de Cytogenetique, Hopital Saint Antoine, Paris, France; Laboratoire de Biologie Moleculaire, Hopital Saint Antoine, Paris, France
Laboratoire de Biologie Moleculaire, Hopital Saint Antoine, Paris, France
Service Hematologie Pediatrique, Hopital Saint Louis, Paris, France
Laboratoire de Biologie Cellulaire Hematopoietique, Service de Medecine Nucleaire, Inserm E0-03, Hopital Saint Louis, Paris, France
CNRS UMR 7000, Faculte de Medecine Pitie-Salpetriere, Paris, France
Service Hemato-Oncologie Pediatrique, Hopital Trousseau, Paris, France
Laboratoire Hematologie, Hopital Robert Debre, Paris, France

* Corresponding author; email: christine.bellanne{at}sat.ap-hop-paris.fr.

Heterozygous mutations of the gene encoding neutrophil elastase (ELA2) have been associated with cyclic neutropenia (CN) and severe congenital neutropenia (SCN). To date, 30 different mutations have been reported, but no correlation has been found with the degree of neutropenia. To address this issue, we analyzed the clinical, hematological and molecular characteristics of 81 unrelated patients with SCN (n=54) or CN (n=27). We identified mutations in 31 patients, two-thirds of whom had sporadic forms. Familial cases were consistent with dominant inheritance. Seventeen novel mutations were identified, showing that the mutational spectrum encompasses not only the region encoding the mature enzyme but also the prodomains and promoter region. Genotype-phenotype analysis strongly suggested that ELA2 mutations correlate with more severe expression of neutropenia, specifically in patients diagnosed with SCN. This study underlines the importance of ELA2 molecular screening to identify patients who may be at particular risk of severe bacterial infections and/or acute myeloid leukaemia/myelodysplasia. By phenotypic analysis of affected relatives and carriers of the same ELA2 mutations, we showed that the expression of neutropenia in CN and SCN may be either homogeneous or variable according to the type of mutations, suggesting different pathogenetic mechanisms.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Neutrophil elastase and neutropenia
David C. Dale
Blood 2004 103: 3993-3994. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. J. Salipante, M. E. B. Rojas, B. Korkmaz, Z. Duan, J. Wechsler, K. F. Benson, R. E. Person, H. L. Grimes, and M. S. Horwitz
Contributions to Neutropenia from PFAAP5 (N4BP2L2), a Novel Protein Mediating Transcriptional Repressor Cooperation between Gfi1 and Neutrophil Elastase
Mol. Cell. Biol., August 15, 2009; 29(16): 4394 - 4405.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
N Ishikawa, S Okada, M Miki, K Shirao, H Kihara, M Tsumura, K Nakamura, H Kawaguchi, M Ohtsubo, S Yasunaga, et al.
Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene
J. Med. Genet., December 1, 2008; 45(12): 802 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G P Spickett
Immune deficiency disorders involving neutrophils
J. Clin. Pathol., September 1, 2008; 61(9): 1001 - 1005.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. T. Teo, R. Klaassen, C. V. Fernandez, R. Yanofsky, J. Wu, J. Champagne, M. Silva, J. H. Lipton, J. Brossard, Y. Samson, et al.
Clinical and Genetic Analysis of Unclassifiable Inherited Bone Marrow Failure Syndromes
Pediatrics, July 1, 2008; 122(1): e139 - e148.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Berliner
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Blood, June 15, 2008; 111(12): 5427 - 5432.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. S. Grenda, M. Murakami, J. Ghatak, J. Xia, L. A. Boxer, D. Dale, M. C. Dinauer, and D. C. Link
Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis
Blood, December 15, 2007; 110(13): 4179 - 4187.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Andersson, J. Karlsson, G. Carlsson, and K. Putsep
Expression of granule-associated proteins in neutrophils from patients with severe congenital neutropenia
Blood, October 1, 2007; 110(7): 2772 - 2773.
[Full Text] [PDF]


Home page
BloodHome page
R. Badolato, M. Donini, G. Savoldi, and S. Dusi
Response: ELA2 genotype-phenotype correlation to be expected in patients with severe congenital neutropenia
Blood, October 1, 2007; 110(7): 2773 - 2774.
[Full Text] [PDF]


Home page
BloodHome page
M. Donini, S. Fontana, G. Savoldi, W. Vermi, L. Tassone, F. Gentili, E. Zenaro, D. Ferrari, L. D. Notarangelo, F. Porta, et al.
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms
Blood, June 1, 2007; 109(11): 4716 - 4723.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante
Neutrophil elastase in cyclic and severe congenital neutropenia
Blood, March 1, 2007; 109(5): 1817 - 1824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Germeshausen, M. Ballmaier, and K. Welte
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey
Blood, January 1, 2007; 109(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Kollner, B. Sodeik, S. Schreek, H. Heyn, N. von Neuhoff, M. Germeshausen, C. Zeidler, M. Kruger, B. Schlegelberger, K. Welte, et al.
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response
Blood, July 15, 2006; 108(2): 493 - 500.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. S. Rosenberg, B. P. Alter, A. A. Bolyard, M. A. Bonilla, L. A. Boxer, B. Cham, C. Fier, M. Freedman, G. Kannourakis, S. Kinsey, et al.
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
Blood, June 15, 2006; 107(12): 4628 - 4635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Zhuang, Y. Qiu, S. C. Kogan, and F. Dong
Increased CCAAT Enhancer-binding Protein {epsilon} (C/EBP{epsilon}) Expression and Premature Apoptosis in Myeloid Cells Expressing Gfi-1 N382S Mutant Associated with Severe Congenital Neutropenia
J. Biol. Chem., April 21, 2006; 281(16): 10745 - 10751.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Horwitz
Neutrophil elastase unleashed
Blood, May 1, 2005; 105(9): 3392 - 3393.
[Full Text] [PDF]


Home page
BloodHome page
P. Massullo, L. J. Druhan, B. A. Bunnell, M. G. Hunter, J. M. Robinson, C. B. Marsh, and B. R. Avalos
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes
Blood, May 1, 2005; 105(9): 3397 - 3404.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. Berliner, M. Horwitz, and T. P. Loughran Jr.
Congenital and Acquired Neutropenia
Hematology, January 1, 2004; 2004(1): 63 - 79.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020